(9S,13S)-1-(1-(2-(2-(2-[18F]Fluoroethoxy)Ethoxy)Ethyl)-1H-1,2,3-Triazol-4-Yl)-3,11-Dioxo-2,4,10,12-Tetraazapentadecane-9,13,15-Tricarboxylicacid

1 trials VVarious

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

1 Countries

Phase III

Phase III: 1

Sponsors using this IMP

Curium Austria GmbH 1

All trials

1 total

Clinical use of [18F]florastamine PET/CT in patients with PI-RADS≤3 report of multi-parametric MRI and suspected prostate cancer Ended

2023-510421-14-00 Phase III 1 country Curium Austria GmbH

Showing 1–1 of 1 trials

← All drugs A–Z